These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3533682)
21. Fasting enhances glycogen synthase activation in hepatocytes from insulin-resistant genetically obese (fa/fa) rats. van de Werve G Biochem J; 1990 Aug; 269(3):789-94. PubMed ID: 1697164 [TBL] [Abstract][Full Text] [Related]
22. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762 [TBL] [Abstract][Full Text] [Related]
23. Non-steady-state measurement of glucose turnover in rats by using a one-compartment model. Proietto J; Rohner-Jeanrenaud F; Ionescu E; Terrettaz J; Sauter JF; Jeanrenaud B Am J Physiol; 1987 Jan; 252(1 Pt 1):E77-84. PubMed ID: 3812676 [TBL] [Abstract][Full Text] [Related]
24. Improved glucose tolerance by acute vanadate but not by selenate exposure in genetically obese rats (fa/fa). Fürnsinn C; Leitner G; Roden M; Osterode W; Waldhäusl W Int J Obes Relat Metab Disord; 1995 Jul; 19(7):458-63. PubMed ID: 8520634 [TBL] [Abstract][Full Text] [Related]
25. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. King PA; Horton ED; Hirshman MF; Horton ES J Clin Invest; 1992 Oct; 90(4):1568-75. PubMed ID: 1401086 [TBL] [Abstract][Full Text] [Related]
26. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats. Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581 [TBL] [Abstract][Full Text] [Related]
27. Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes. Hirshman MF; Fagnant PM; Horton ED; King PA; Horton ES Biochem Biophys Res Commun; 1995 Mar; 208(2):835-45. PubMed ID: 7695642 [TBL] [Abstract][Full Text] [Related]
29. Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Brichard SM; Pottier AM; Henquin JC Endocrinology; 1989 Nov; 125(5):2510-6. PubMed ID: 2676485 [TBL] [Abstract][Full Text] [Related]
30. Intestinal glucose absorption is lower in obese than in lean Zucker rats. García-Martínez C; López-Soriano FJ; Argilés JM J Nutr; 1993 Jun; 123(6):1062-7. PubMed ID: 8505666 [TBL] [Abstract][Full Text] [Related]
31. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats. Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309 [TBL] [Abstract][Full Text] [Related]
32. Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Down-Regulation of Protein Tyrosine Phosphatase 1B in Obese Rats. Mu S; Liu J; Guo W; Zhang S; Xiao X; Wang Z; Zhang J Obes Facts; 2017; 10(3):191-206. PubMed ID: 28564652 [TBL] [Abstract][Full Text] [Related]
33. Effect of sleeve gastrectomy on body weight, food intake, glucose tolerance, and metabolic hormone level in two different rat models: Goto-Kakizaki and diet-induced obese rat. Trung VN; Yamamoto H; Yamaguchi T; Murata S; Akabori H; Ugi S; Maegawa H; Tani T J Surg Res; 2013 Nov; 185(1):159-65. PubMed ID: 23746960 [TBL] [Abstract][Full Text] [Related]
34. Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM. Jeanrenaud B Diabetologia; 1994 Sep; 37 Suppl 2():S170-8. PubMed ID: 7821733 [TBL] [Abstract][Full Text] [Related]
35. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303 [TBL] [Abstract][Full Text] [Related]
36. Ocular complications in the old and glucose-intolerant genetically obese (fa/fa) rat. Dosso A; Rungger-Brändle E; Rohner-Jeanrenaud F; Ionescu E; Guillaume-Gentil C; Jeanrenaud B; Leuenberger PM Diabetologia; 1990 Mar; 33(3):137-44. PubMed ID: 2184064 [TBL] [Abstract][Full Text] [Related]
37. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats. Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT Life Sci; 2006 Jun; 79(3):240-6. PubMed ID: 16458327 [TBL] [Abstract][Full Text] [Related]
38. Relationship between increased binding and insulin-like effects of human growth hormone in adipocytes from young fa/fa rats. Landron D; Guerre-Millo M; Postel-Vinay MC; Lavau M Endocrinology; 1989 May; 124(5):2305-13. PubMed ID: 2651095 [TBL] [Abstract][Full Text] [Related]
39. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity. Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956 [TBL] [Abstract][Full Text] [Related]
40. Gastric inhibitory polypeptide and hyperinsulinemia in the Zucker (fa/fa) rat: a developmental study. Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC Int J Obes; 1985; 9(2):137-46. PubMed ID: 3897081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]